NCT02953132

A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers

A Randomised, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of MT-4129 in Healthy Subjects; Including the Effect of Gender and Age on the Pharmacokinetics of a Single Dose of MT-4129 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 116 (estimated)
• Sponsor: Tanabe Pharma Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the safety and tolerability of ascending single and multiple oral doses of MT-4129 in healthy subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	MT-4129
DRUG	Placebo

Timeline

• Start date: 2016-11-01
• Primary completion: 2017-05-01
• Completion: 2017-05-01
• First posted: 2016-11-02
• Last updated: 2017-05-18

Locations

1 site across 1 country: Netherlands